Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mical Paul

Showing results (301-310 of 343) with videos related to

Pageof 35
Sort By:
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 16, 2026
Cat Scratch Disease Encephalitis: New Insights into Rate, Clinical Features, and Long-Term OutcomesMichal Yakubovsky, Laliv Kadar, Eugene Katchman, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2026
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBaAnna L Goodman, Nicholas Easom, Dana Bielopolski, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 19, 2021
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Elena Carrara, Pilar Retamar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 3, 2023
Host test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating bacterial and viral respiratory tract infections in adults: diagnostic accuracy studySalim Halabi, Shachaf Shiber, Meital Paz, et al.
Antimicrobial Resistance and Infection Control|November 5, 2025
Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trialAmir Nutman, Elizabeth Temkin, Jonathan Lellouche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Pageof 35

Showing results (301-310 of 343) with videos related to

Sort By:
Pageof 35
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 16, 2026
Cat Scratch Disease Encephalitis: New Insights into Rate, Clinical Features, and Long-Term OutcomesMichal Yakubovsky, Laliv Kadar, Eugene Katchman, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2026
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBaAnna L Goodman, Nicholas Easom, Dana Bielopolski, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 19, 2021
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Elena Carrara, Pilar Retamar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 3, 2023
Host test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating bacterial and viral respiratory tract infections in adults: diagnostic accuracy studySalim Halabi, Shachaf Shiber, Meital Paz, et al.
Antimicrobial Resistance and Infection Control|November 5, 2025
Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trialAmir Nutman, Elizabeth Temkin, Jonathan Lellouche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Pageof 35